Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods

An hemodialysis population in Central Brazil was screened by polymerase chain reaction (PCR) and serological methods to assess the prevalence of hepatitis C virus (HCV) infection and to investigate associated risk factors. All hemodialysis patients (n=428) were interviewed in eight dialysis units in Goiânia city. Blood samples were collected and serum samples screened for anti-HCV antibodies by an enzyme-linked immunosorbent assay (ELISA). Positive samples were retested for confirmation with a line immunoassay (LIA). All samples were also tested for HCV RNA by the PCR. An overall prevalence of 46.7% (CI 95%: 42-51.5) was found, ranging from 20.7% (CI 95%: 8.8-38.1) to 90.4% (CI 95%: 79.9-96.4) depending on the dialysis unit. Of the 428 patients, 185 were found to be seropositive by ELISA, and 167 were confirmed positive by LIA, resulting in an anti-HCV prevalence of 39%. A total of 131 patients were HCV RNA-positive. HCV viremia was present in 63.5% of the anti-HCV-positive patients and in 10.3% of the anti-HCV-negative patients. Univariate analysis of risk factors showed that the number of previous blood transfusions, transfusion of blood before mandatory screening for anti-HCV, length of time on hemodialysis, and treatment in multiple units were associated with HCV positivity. However, multivariate analysis revealed that blood transfusion before screening for anti-HCV and length of time on hemodialysis were significantly associated with HCV infection in this population. These data suggest that nosocomial transmission may play a role in the spread of HCV in the dialysis units studied. In addition to anti-HCV screening, HCV RNA detection is necessary for the diagnosis of HCV infection in hemodialysis patients.

Saved in:
Bibliographic Details
Main Authors: Carneiro,Megmar AS, Martins,Regina MB, Teles,Sheila A, Silva,Simonne A, Lopes,Carmen L, Cardoso,Divina DP, Vanderborght,Bart OM, Yoshida,Clara FT
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2001
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762001000600003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762001000600003
record_format ojs
spelling oai:scielo:S0074-027620010006000032001-08-23Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methodsCarneiro,Megmar ASMartins,Regina MBTeles,Sheila ASilva,Simonne ALopes,Carmen LCardoso,Divina DPVanderborght,Bart OMYoshida,Clara FT hepatitis C hemodialysis prevalence risk factors Central Brazil An hemodialysis population in Central Brazil was screened by polymerase chain reaction (PCR) and serological methods to assess the prevalence of hepatitis C virus (HCV) infection and to investigate associated risk factors. All hemodialysis patients (n=428) were interviewed in eight dialysis units in Goiânia city. Blood samples were collected and serum samples screened for anti-HCV antibodies by an enzyme-linked immunosorbent assay (ELISA). Positive samples were retested for confirmation with a line immunoassay (LIA). All samples were also tested for HCV RNA by the PCR. An overall prevalence of 46.7% (CI 95%: 42-51.5) was found, ranging from 20.7% (CI 95%: 8.8-38.1) to 90.4% (CI 95%: 79.9-96.4) depending on the dialysis unit. Of the 428 patients, 185 were found to be seropositive by ELISA, and 167 were confirmed positive by LIA, resulting in an anti-HCV prevalence of 39%. A total of 131 patients were HCV RNA-positive. HCV viremia was present in 63.5% of the anti-HCV-positive patients and in 10.3% of the anti-HCV-negative patients. Univariate analysis of risk factors showed that the number of previous blood transfusions, transfusion of blood before mandatory screening for anti-HCV, length of time on hemodialysis, and treatment in multiple units were associated with HCV positivity. However, multivariate analysis revealed that blood transfusion before screening for anti-HCV and length of time on hemodialysis were significantly associated with HCV infection in this population. These data suggest that nosocomial transmission may play a role in the spread of HCV in the dialysis units studied. In addition to anti-HCV screening, HCV RNA detection is necessary for the diagnosis of HCV infection in hemodialysis patients.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.96 n.6 20012001-08-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762001000600003en10.1590/S0074-02762001000600003
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Carneiro,Megmar AS
Martins,Regina MB
Teles,Sheila A
Silva,Simonne A
Lopes,Carmen L
Cardoso,Divina DP
Vanderborght,Bart OM
Yoshida,Clara FT
spellingShingle Carneiro,Megmar AS
Martins,Regina MB
Teles,Sheila A
Silva,Simonne A
Lopes,Carmen L
Cardoso,Divina DP
Vanderborght,Bart OM
Yoshida,Clara FT
Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
author_facet Carneiro,Megmar AS
Martins,Regina MB
Teles,Sheila A
Silva,Simonne A
Lopes,Carmen L
Cardoso,Divina DP
Vanderborght,Bart OM
Yoshida,Clara FT
author_sort Carneiro,Megmar AS
title Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
title_short Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
title_full Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
title_fullStr Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
title_full_unstemmed Hepatitis C prevalence and risk factors in hemodialysis patients in Central Brazil: a survey by polymerase chain reaction and serological methods
title_sort hepatitis c prevalence and risk factors in hemodialysis patients in central brazil: a survey by polymerase chain reaction and serological methods
description An hemodialysis population in Central Brazil was screened by polymerase chain reaction (PCR) and serological methods to assess the prevalence of hepatitis C virus (HCV) infection and to investigate associated risk factors. All hemodialysis patients (n=428) were interviewed in eight dialysis units in Goiânia city. Blood samples were collected and serum samples screened for anti-HCV antibodies by an enzyme-linked immunosorbent assay (ELISA). Positive samples were retested for confirmation with a line immunoassay (LIA). All samples were also tested for HCV RNA by the PCR. An overall prevalence of 46.7% (CI 95%: 42-51.5) was found, ranging from 20.7% (CI 95%: 8.8-38.1) to 90.4% (CI 95%: 79.9-96.4) depending on the dialysis unit. Of the 428 patients, 185 were found to be seropositive by ELISA, and 167 were confirmed positive by LIA, resulting in an anti-HCV prevalence of 39%. A total of 131 patients were HCV RNA-positive. HCV viremia was present in 63.5% of the anti-HCV-positive patients and in 10.3% of the anti-HCV-negative patients. Univariate analysis of risk factors showed that the number of previous blood transfusions, transfusion of blood before mandatory screening for anti-HCV, length of time on hemodialysis, and treatment in multiple units were associated with HCV positivity. However, multivariate analysis revealed that blood transfusion before screening for anti-HCV and length of time on hemodialysis were significantly associated with HCV infection in this population. These data suggest that nosocomial transmission may play a role in the spread of HCV in the dialysis units studied. In addition to anti-HCV screening, HCV RNA detection is necessary for the diagnosis of HCV infection in hemodialysis patients.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2001
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762001000600003
work_keys_str_mv AT carneiromegmaras hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT martinsreginamb hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT telessheilaa hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT silvasimonnea hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT lopescarmenl hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT cardosodivinadp hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT vanderborghtbartom hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
AT yoshidaclaraft hepatitiscprevalenceandriskfactorsinhemodialysispatientsincentralbrazilasurveybypolymerasechainreactionandserologicalmethods
_version_ 1756383390902255616